• Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
  • Log In
    • Register
Contacts us @ MediPr.org
Medical News Asia | Powered by ['mediPr]
  • MDnews
  • About [‘mediPr]
  • HER2 Explorer
  • TROP Tool
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
Scroll to next section Scroll to next section

Non-Sponsored Content


CARDIOVASCULAR DISEASE

有關疫苗的虛假信息

Medical writer: Dr Siddharth Sridhar | Last updated: 11 January 2021 | In: COVID-19, SARS-CoV2, Pneumonia, Infectious Disease, Vaccines

Article Keywords

Moderna, mRNA-1273, Sinovac, Pfizer, WARS, tozinameran, AZ, SARS-CoV-2, China, AZD1222, 2019-nCoV, BioNTech, corona virus, BNT162b2, COVID-19, ChAdOx1-nCoV-19, CoronaVac, Fosun Pharma, pneumonia

我最近在YouTube頻道上看到這條在2020年12月17日發佈的視頻(https://www.youtube.com/watch?v=RYCwCOGCu9A&feature=youtu.be),聲稱說明有關COVID-19疫苗的功效和風險。該視頻的內容非常不準確且具有誤導性。 令我震驚的是,該視頻已吸引了超過三十萬觀看者,其中有幾位評論者表示同意偽科學。

視頻裡的講者提出了多項主張,我對此進行了事實核查:

1.他聲稱SARS-CoV-2的棘突蛋白可通過與人類細胞上的EGFR結合而直接導致肺纖維化(永久組織變硬)。這就是他認為COVID-19引起肺炎的方式。

事實核查:這是不正確的。大多數COVID-19患者沒有發展成永久性肺纖維化,只有少數患者由於嚴重的肺損傷才會。肺纖維化是任何嚴重肺炎的潛在後果,而不僅僅是COVID-19。纖維化是組織受到損傷後形成的一種疤痕,它不受病毒尖刺控制,而是源自人體修復的過程。具體而言,沒有證據表明尖刺有“甲基轉移酶”的作用。他引用的“ NSP16”是功能完全不同的基因產物。

2.他指出製藥公司“不敢”製作滅活病毒疫苗,因為它們仍然會引起疾病。

事實核查:幾間公司和大學正在研究SARS-CoV-2滅活病毒疫苗。而疫苗還未可應用的原因,僅僅是因為“弱化”病毒和驗證弱化效果的過程需要花費很多時間,因此無法迅速推出。 我相信在未來幾年內試用滅活病毒疫苗。

3.他特別指出,mRNA疫苗不能抵禦COVID-19,因為它們會刺激生產一種稱為IgG的抗體。他提出了怪異的說法,就是IgG不能抵禦COVID-19,因為它存在於血液而不是肺中。

事實核查:完全是錯誤的。當該視頻發佈到YouTube時,輝瑞和Moderna研發的疫苗試驗結果已經發佈,這無疑證明了疫苗的有效預防率達九成以上。這意味著,與未接種疫苗的人士相比,接種疫苗的人士患上COVID-19的可能性降低了百份之九十以上。IgG可以預防COVID-19,因為在我們需要預防COVID-19的肺部深處的肺泡上皮液中也發現了IgG。另外,他認為產生IgA的吸入性疫苗是一種有吸引力的選擇也算是正確,並且多個機構(包括香港大學)都在積極研發這類疫苗,但毫無疑問,目前已獲批的疫苗可有效抵抗COVID-19。他要麼不知道,要麼就是故意無視mRNA疫苗的第三期隨機對照試驗的結果。

4.最危險的是他接著提出的另一種說法,即因為mRNA能進入腎臟和肝臟而其疫苗可引致多器官纖維化。

事實核查:這是絕對沒有任何理論或事實依據。實際上,注射mRNA疫苗後會在我們的身體中表達少量尖刺蛋白,及後便會迅速降解,而所產生的尖刺蛋白便足以激發強大的免疫反應,僅此而已。而且,不論是mRNA或是尖刺蛋白均未發現積聚在器官內。另外,這也揭穿他於上述第1點有關尖刺蛋白直接導致纖維化的假說。

5.最後,他介紹了許多可能對抗COVID-19有用的營養補品

事實核查:零證據。 他提到的“對接”是一種基於計算機的靈活模擬方法,用於查看某些分子是否可以與SARS-CoV-2蛋白產生相互作用。除非有可靠的臨床前和臨床試驗證據來支持,否則會產生很多關於“對接”的發現而不能得到證實。

這是有關疫苗的一種最危險和有害的虛假信息,似乎是由受過某些科學訓練的人寫下的偽科學。對於不熟悉課題的觀眾來說,很難區分事實和捏造。對我們每個人來說,應避免於自己家庭的Whatsapp群組和Facebook時間線上發佈這種虛假信息,是十分重要的。

堅持核實事實,祝周末愉快!


YOU MAY ALSO LIKE

MPR-FOS-2023019 HKMA HKSID Launch 4 MAR

Achieving the Best Outcomes under COVID-19 Endemicity

https://medi-paper.com/wp-content/uploads/2023/05/MPR-FOS-2023019-HKMA-HKSID-Launch-4-MAR-scaled.jpg 1366 2560 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-05-17 12:25:412023-05-31 12:39:03Achieving the Best Outcomes under COVID-19 Endemicity
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

https://medi-paper.com/wp-content/uploads/2023/01/INACTIVATED-AND-mRNA-COVID-19-VACCINES-IN-PATIENTS-WITH-AUTOIMMUNE-RHEUMATIC-DISEASES-–-A-CITY-OF-TWO-TALES.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-30 10:47:542023-02-02 16:50:53Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

https://medi-paper.com/wp-content/uploads/2023/01/Late-but-sinister-post-COVID-19-conditions_new-onset-rheumatic-diseases.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 12:18:572023-03-08 12:48:36Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

https://medi-paper.com/wp-content/uploads/2023/01/COVID-19-Infection-and-Subfertility-A-Subtle-and-Debatable-Complication.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 11:32:342023-01-19 18:28:49COVID-19 Infection and Subfertility: A Subtle and Debatable Complication
Previous Previous Previous Next Next Next
MPR-FOS-2023019 HKMA HKSID Launch 4 MAR
17 May 2023

Achieving the Best Outcomes under COVID-19 Endemicity

INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES
30 January 2023

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

Disclaimer

This article is not medical advice. Patients should seek personal assessment by a licenced specialist. Physicians are recommended to read the full publication(s) as cited in the article before making medical decisions. This article does not supersede nor replace the published article(s).

© Copyright 2021 MediPaper Medical Communications Ltd. – 有關疫苗的虛假信息

YOU MAY ALSO LIKE

MPR-FOS-2023019 HKMA HKSID Launch 4 MAR

Achieving the Best Outcomes under COVID-19 Endemicity

https://medi-paper.com/wp-content/uploads/2023/05/MPR-FOS-2023019-HKMA-HKSID-Launch-4-MAR-scaled.jpg 1366 2560 Jeffrey Martin https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Jeffrey Martin2023-05-17 12:25:412023-05-31 12:39:03Achieving the Best Outcomes under COVID-19 Endemicity
INACTIVATED AND mRNA COVID-19 VACCINES IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES – A CITY OF TWO TALES

Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales

https://medi-paper.com/wp-content/uploads/2023/01/INACTIVATED-AND-mRNA-COVID-19-VACCINES-IN-PATIENTS-WITH-AUTOIMMUNE-RHEUMATIC-DISEASES-–-A-CITY-OF-TWO-TALES.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-30 10:47:542023-02-02 16:50:53Inactivated and mRNA COVID-19 vaccines in patients with autoimmune rheumatic diseases – A city of two tales
Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases

https://medi-paper.com/wp-content/uploads/2023/01/Late-but-sinister-post-COVID-19-conditions_new-onset-rheumatic-diseases.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 12:18:572023-03-08 12:48:36Late but sinister post-COVID-19 conditions: new-onset rheumatic diseases
COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

COVID-19 Infection and Subfertility: A Subtle and Debatable Complication

https://medi-paper.com/wp-content/uploads/2023/01/COVID-19-Infection-and-Subfertility-A-Subtle-and-Debatable-Complication.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2023-01-16 11:32:342023-01-19 18:28:49COVID-19 Infection and Subfertility: A Subtle and Debatable Complication
COVID-19 vaccine booster strategy: Striving for the best

COVID-19 VACCINE BOOSTER STRATEGY: STRIVING FOR THE BEST

https://medi-paper.com/wp-content/uploads/2023/01/COVID-19-vaccine-booster-strategy_Striving-for-the-best.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2023-01-16 10:03:242024-04-10 14:28:47COVID-19 VACCINE BOOSTER STRATEGY: STRIVING FOR THE BEST
Protection is Never Premature_Maternal COVID-19 Infection and Adverse Perinatal Outcomes

Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

https://medi-paper.com/wp-content/uploads/2022/12/Protection-is-Never-Premature_Maternal-COVID-19-Infection-and-Adverse-Perinatal-Outcomes.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-12-05 11:58:442023-03-08 12:42:36Protection is Never Premature: Maternal COVID-19 Infection is Associated with Adverse Perinatal Outcomes

Updates on COVID-19 Vaccine Booster in Omicron Era

https://medi-paper.com/wp-content/uploads/2022/12/Updates-on-COVID-19-Vaccine-Booster-in-Omicron-Era_A.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-12-05 10:59:142022-12-06 15:49:40Updates on COVID-19 Vaccine Booster in Omicron Era
Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents

https://medi-paper.com/wp-content/uploads/2022/11/Should-your-child-receive-covid-19-vaccination.-Risk-benefit-analyses-in-infants-children-and-adolescents.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-11-07 02:14:052022-11-09 03:12:41Should your child receive covid-19 vaccination? Risk-benefit analyses in infants, children, and adolescents
At the Heart of the Discussion: COVID-19 Cardiovascular Complications in the Pregnant Women

At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women

https://medi-paper.com/wp-content/uploads/2022/11/At-the-Heart-of-the-Discussion.-COVID-19-Cardiovascular-Complications-in-the-Pregnant-Women.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-11-06 07:53:422022-11-07 08:56:16At the Heart of the Discussion: COVID-19 Cardiovascular Complications in Pregnant Women
Covid-19 vaccination safety and effectiveness for pregnant and lactating women

Covid-19 vaccination safety and effectiveness for pregnant and lactating women

https://medi-paper.com/wp-content/uploads/2022/10/Covid-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women.jpg 1024 1918 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2022-10-25 06:03:462022-10-25 07:52:49Covid-19 vaccination safety and effectiveness for pregnant and lactating women
Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients

https://medi-paper.com/wp-content/uploads/2022/08/Dr-Ho-SO-–-Vaccination-Safety-and-Effectiveness-in-Immunocompromised-Patients.jpg 1024 1918 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2022-08-26 05:25:062022-09-19 11:29:45HKMA CME Live Lecture: Dr Ho SO – Vaccination Safety and Effectiveness in Immunocompromised Patients
Vaccination versus Active Infection_A Comparison of the Cardiovascular Risks

Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Vaccination-versus-Active-Infection_A-Comparison-of-the-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 03:30:452022-08-30 10:51:31Vaccination versus Active Infection: A Comparison of the Cardiovascular Risks
Common Respiratory Viruses and Their Associated Cardiovascular Risks

Common Respiratory Viruses and Their Associated Cardiovascular Risks

https://medi-paper.com/wp-content/uploads/2022/08/Common-Respiratory-Viruses-and-Their-Associated-Cardiovascular-Risks.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-08-26 02:02:012022-08-30 10:51:35Common Respiratory Viruses and Their Associated Cardiovascular Risks
Strategy for COVID-19 vaccination: Disease control, elimination or eradication

Strategy for COVID-19 vaccination: Disease control, elimination or eradication?

https://medi-paper.com/wp-content/uploads/2022/07/Strategy-for-COVID-19-vaccination-Disease-control-elimination-or-eradication.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-07-12 07:00:302022-07-13 05:40:30Strategy for COVID-19 vaccination: Disease control, elimination or eradication?
SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

SARS-CoV-2 evolution in the COVID-19 era: Three years and counting

https://medi-paper.com/wp-content/uploads/2022/07/SARS-CoV-2-evolution-in-the-COVID-19-era-Three-years-and-counting.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:39:322022-07-12 09:20:40SARS-CoV-2 evolution in the COVID-19 era: Three years and counting
UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

UK statistics suggest COVID-19 variant types as “long COVID” progression predictors

https://medi-paper.com/wp-content/uploads/2022/07/UK-statistics-suggest-COVID-19-variant-types-as-long-COVID-progression-predictors.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-07-08 08:01:272022-07-12 09:10:35UK statistics suggest COVID-19 variant types as “long COVID” progression predictors
COVID-19 ANTIVIRAL TREATMENT AND BOOSTER VACCINE EFFECTIVENESS

COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness

https://medi-paper.com/wp-content/uploads/2022/06/MPR-FOS-2022003_1918x1024.jpg 1024 1918 Kathlin Ambrose https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kathlin Ambrose2022-06-21 02:46:572022-07-13 05:48:31COVID-19 Antiviral Treatment and Booster Vaccine Effectiveness
Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme

https://medi-paper.com/wp-content/uploads/2022/06/HIV-cover-photo.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-20 07:49:562022-06-28 11:33:57Feasibility of Implementing Population-Wide Opt-Out HIV Testing Scheme
An Overview of the South African COVID-19 Subvariant Outbreak: How Serious is It?

An Overview of the South African COVID-19 Subvariant Outbreak

https://medi-paper.com/wp-content/uploads/2022/06/cover-photo-1918x1024-1.jpg 1024 1918 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-06-17 02:30:592022-06-28 11:55:35An Overview of the South African COVID-19 Subvariant Outbreak
COVID-19 Vaccinations in Adolescents and Children

COVID-19 Vaccinations in Adolescents and Children

https://medi-paper.com/wp-content/uploads/2022/05/COVID-19-Vaccinations-in-Adolescents-and-Children-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-30 07:01:232022-07-13 05:54:09COVID-19 Vaccinations in Adolescents and Children
Monkeypox Virus: How Likely is a Local Outbreak?

Monkeypox Virus: How Likely is a Local Outbreak?

https://medi-paper.com/wp-content/uploads/2022/05/Monkeypox-Virus_How-Likely-is-a-Local-Outbreak-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-30 05:32:332022-05-31 05:58:12Monkeypox Virus: How Likely is a Local Outbreak?
Local Updates on COVID-19 Prevention and Treatment

Local Updates on COVID-19 Prevention and Treatment

https://medi-paper.com/wp-content/uploads/2022/05/Local-Updates-on-COVID-19-Prevention-and-Treatment-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-30 04:49:162022-05-31 11:25:18Local Updates on COVID-19 Prevention and Treatment
Tolerability of COVID-19 vaccines in patients with cancer

Tolerability of COVID-19 vaccines in patients with cancer

https://medi-paper.com/wp-content/uploads/2022/05/Tolerability-of-COVID-19-vaccines-in-patients-with-cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-17 02:20:592022-05-17 05:46:03Tolerability of COVID-19 vaccines in patients with cancer
US and Chinese Studies Suggest More Severe Outcomes in COVID-19 Patients with Cancer

More Severe Outcomes in COVID-19 Patients with Cancer

https://medi-paper.com/wp-content/uploads/2022/05/US-and-Chinese-Studies-Suggest-More-Severe-Outcomes-in-COVID-19-Patients-with-Cancer-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-05-16 08:12:092022-05-17 05:46:03More Severe Outcomes in COVID-19 Patients with Cancer
COVID-19 vaccination safety and effectiveness for pregnant and lactating women

COVID-19 vaccination safety and effectiveness for pregnant and lactating women

https://medi-paper.com/wp-content/uploads/2022/05/COVID-19-vaccination-safety-and-effectiveness-for-pregnant-and-lactating-women-scaled.jpg 1367 2560 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-05-03 02:34:242022-05-17 05:46:03COVID-19 vaccination safety and effectiveness for pregnant and lactating women
Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)

https://medi-paper.com/wp-content/uploads/2022/04/Gut-Microbiome-Predictor-for-COVID-19-Vaccine-Response-and-Safety-CZ02-and-BNT162b2-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 10:30:502022-05-17 05:46:03Gut Microbiome: Predictor for COVID-19 Vaccine Response and Safety (CZ02 and BNT162b2)
US Study Suggests A Lesser-known COVID-19 Complication Diabetes Mellitus

US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus

https://medi-paper.com/wp-content/uploads/2022/04/US-Study-Suggests-A-Lesser-known-COVID-19-Complication-Diabetes-Mellitus-scaled.jpg 1367 2560 Christy Leung https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Christy Leung2022-04-29 05:47:272022-05-17 05:46:03US Study Suggests A Lesser-known COVID-19 Complication: Diabetes Mellitus
Vaccination Strategies and Management Against Omicron Outbreak

Vaccination Strategies and Management Against Omicron Outbreak

https://medi-paper.com/wp-content/uploads/2022/03/Vaccination-Strategies-and-Management-Against-Omicron-Outbreak.png 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-04-01 03:37:202022-05-17 05:46:03Vaccination Strategies and Management Against Omicron Outbreak
UK study_Infected adolescents are at higher risk of long COVID symptoms

UK study: Infected adolescents are at higher risk of long COVID symptoms

https://medi-paper.com/wp-content/uploads/2022/03/UK-study_Infected-adolescents-are-at-higher-risk-of-long-COVID-symptoms.jpg 1024 1918 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2022-03-01 07:20:182022-05-17 05:46:03UK study: Infected adolescents are at higher risk of long COVID symptoms
Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

https://medi-paper.com/wp-content/uploads/2022/02/Antiviral-Molnupiravir-Associated-with-Reduced-Risk-of-Hospitalisation-or-Death-in-COVID-19-Patients.jpg 1024 1918 Chloe FUNG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Chloe FUNG2022-02-28 07:41:092022-05-17 05:46:03Antiviral Molnupiravir Associated with Reduced Risk of Hospitalisation or Death in COVID-19 Patients

Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

https://medi-paper.com/wp-content/uploads/2021/12/Anti-TNF-Therapy-Correlated-with-Better-Outcomes-in-IBD-Patients-with-COVID-19.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-20 12:58:472022-05-17 05:46:03Anti-TNF Therapy Correlated with Better Outcomes in IBD Patients with COVID-19

The use of COVID-19 vaccines in children and adolescents

https://medi-paper.com/wp-content/uploads/2021/12/The-use-of-COVID-19-vaccines-in-children-and-adolescents.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-16 11:53:112022-05-17 05:46:03The use of COVID-19 vaccines in children and adolescents
HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3

HPV immunisation in UK lowers the incidence of cervical cancer and CIN3

https://medi-paper.com/wp-content/uploads/2021/12/HPV-immunisation-in-UK-lowers-the-incidence-of-cervical-cancer-and-CIN3.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-12-06 16:33:152022-02-20 10:34:01HPV immunisation in UK lowers the incidence of cervical cancer and CIN3
Combination-therapy-with-a-novel-agent-albuvirtide-in-hospitalised-AIDs-patients

Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients

https://medi-paper.com/wp-content/uploads/2021/11/Combination-therapy-with-a-novel-agent-albuvirtide-in-hospitalised-AIDs-patients.jpg 1024 1917 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-11-03 23:59:572022-02-19 05:11:56Combination therapy with a novel agent, albuvirtide, in hospitalised AIDS patients
Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years

BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?

https://medi-paper.com/wp-content/uploads/2021/11/Pfizer-BioNTech-COVID-19-Vaccine-for-Ages-5-to-11-Years.jpg 1024 1917 Catalina FOK https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Catalina FOK2021-11-03 15:29:572022-07-13 05:55:25BioNTech COVID-19 vaccine for ages 5 to 11 years – To jab or not to jab?
Gender-related-differences-in-safety

Gender-related differences in safety after switching to BIC/TAF/FTC

https://medi-paper.com/wp-content/uploads/2021/11/Gender-related-differences-in-safety.jpg 1024 1917 Connie TANG https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Connie TANG2021-11-03 14:49:542022-02-20 10:58:03Gender-related differences in safety after switching to BIC/TAF/FTC
Effect-of-HIV-infection-on-growth-and-bone-density-in-peripubertal-children-under-antiretroviral-therapy

Effect of HIV infection on growth and bone density in peripubertal children under antiretroviral therapy

https://medi-paper.com/wp-content/uploads/2021/07/Effect-of-HIV-infection-on-growth-and-bone-density-in-peripubertal-children-under-antiretroviral-therapy.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-20 17:03:522022-02-23 07:54:14Effect of HIV infection on growth and bone density in peripubertal children under antiretroviral therapy
Safety-and-Immunogenicity-of-the-BNT162b2-mRNA-Covid-19-Vaccine-in-Patients-after-Allogeneic-HCT-or-CD19-based-CAR-T-therapy

Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy

https://medi-paper.com/wp-content/uploads/2021/07/Safety-and-Immunogenicity-of-the-BNT162b2-mRNA-Covid-19-Vaccine-in-Patients-after-Allogeneic-HCT-or-CD19-based-CAR-T-therapy.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-20 16:38:402022-05-17 05:46:03Safety and Immunogenicity of the BNT162b2 mRNA Covid-19 Vaccine in Patients after Allogeneic HCT or CD19-based CAR-T therapy
Efficacy-and-safety-of-HIV-fusion-inhibitor-albuvirtide-in-treatment-experienced-patients-from-phase-3-TALENT-study

Efficacy and safety of HIV fusion inhibitor albuvirtide in treatment experienced patients from phase 3 TALENT study

https://medi-paper.com/wp-content/uploads/2021/07/Efficacy-and-safety-of-HIV-fusion-inhibitor-albuvirtide-in-treatment-experienced-patients-from-phase-3-TALENT-study.webp 1024 1917 Coco Chong https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Coco Chong2021-07-15 15:04:522022-02-23 08:15:19Efficacy and safety of HIV fusion inhibitor albuvirtide in treatment experienced patients from phase 3 TALENT study
COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases

COVID-19 impacting regular patient care for cardiovascular diseases

https://medi-paper.com/wp-content/uploads/2021/02/COVID-19-impacting-regular-patient-care-for-cardiovascular-diseases.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-17 11:52:282022-05-17 05:46:03COVID-19 impacting regular patient care for cardiovascular diseases
SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy

SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy

https://medi-paper.com/wp-content/uploads/2021/02/SARS-CoV-2-infection-in-children-and-an-increased-risk-of-thrombotic-microangiopathy.jpg 1024 1918 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2021-02-10 15:41:562022-05-17 05:46:03SARS-CoV-2 infection in children and an increased risk of thrombotic microangiopathy
Evidence-of-SARS-CoV2-in-heart-cells

Evidence of SARS-CoV2 in heart cells

https://medi-paper.com/wp-content/uploads/2020/09/Evidence-of-SARS-CoV2-in-heart-cells.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-22 10:19:272022-05-17 05:46:04Evidence of SARS-CoV2 in heart cells
triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia

Triple combination effective for hospital- and ventilator-acquired pneumonia

https://medi-paper.com/wp-content/uploads/2020/09/triple-combination-effective-for-hospital-and-ventilator-acquired-pneumonia.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-09-10 11:04:232022-02-24 01:58:40Triple combination effective for hospital- and ventilator-acquired pneumonia
risk-of-thrombosis-with-sars-cov-2-infection

Risk of thrombosis with SARS-CoV-2 infection

https://medi-paper.com/wp-content/uploads/2020/08/risk-of-thrombosis-with-sars-cov-2-infection.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-27 16:33:072022-05-17 05:46:04Risk of thrombosis with SARS-CoV-2 infection
no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status

No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status

https://medi-paper.com/wp-content/uploads/2020/08/no-difference-in-kidney-transplantation-outcomes-for-HIV-positive-recipients-regardless-of-donor-HIV-status.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-25 10:15:352022-02-24 03:56:17No difference in kidney transplantation outcomes for HIV-positive recipients regardless of donor HIV status
residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance

Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance

https://medi-paper.com/wp-content/uploads/2020/08/residual-risk-of-hepatocellular-carcinoma-in-older-hepatitis-c-patients-even-after-viral-clearance.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 16:18:002022-02-24 03:58:03Residual risk of hepatocellular carcinoma in older Hepatitis C patients even after viral clearance
potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations

Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations

https://medi-paper.com/wp-content/uploads/2020/08/potential-protective-effects-of-the-influenza-vaccine-on-cardiovascular-outcomes-in-high-risk-populations.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 15:28:132022-02-24 03:59:44Potential protective effects of the influenza vaccine on cardiovascular outcomes in high-risk populations
updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society

Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society

https://medi-paper.com/wp-content/uploads/2020/08/updated-human-papillomavirus-vaccination-and-testing-recommendations-from-the-american-cancer-society.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-13 14:41:322022-02-24 04:10:20Updated human papillomavirus vaccination and testing recommendations from the American Cancer Society
interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV

Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV

https://medi-paper.com/wp-content/uploads/2020/08/interim-results-of-a-Phase-2b-3-trial-investigating-a-long-acting-injectable-of-cabotegravir-for-pre-exposure-prophylaxis-of-HIV.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:44:162022-02-24 04:09:24Interim results of a Phase 2b/3 trial investigating a long-acting injectable of cabotegravir for pre-exposure prophylaxis of HIV
comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis

Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis

https://medi-paper.com/wp-content/uploads/2020/08/comparison-of-the-metabolic-changes-from-the-tango-trial-a-post-hoc-analysis.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-08-04 14:02:232022-02-24 04:14:25Comparison of the metabolic changes from the TANGO trial: a post-hoc analysis
Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer

Carboplatin plus paclitaxel to be the new standard of care for anal cancer

https://medi-paper.com/wp-content/uploads/2020/07/Carboplatin-plus-paclitaxel-to-be-the-new-standard-of-care-for-anal-cancer.jpg 1024 1819 Kirsty LEE https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Kirsty LEE2020-07-10 17:24:482022-02-24 04:17:57Carboplatin plus paclitaxel to be the new standard of care for anal cancer
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-2019新型冠狀病毒肺炎患者的臨床特徵-e1581435553798

更新: Covid-19患者的臨床特徵

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-2019新型冠狀病毒肺炎患者的臨床特徵-e1581435553798.webp 540 720 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:24:412022-05-17 05:46:03更新: Covid-19患者的臨床特徵
Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128

Updated: Clinical characteristics of patients with COVID-19

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Clinical-characteristics-of-patients-with-2019-nCoV-pneumonia-WARS-Wuhan-Pneumonia-coronavirus-outbreak-sars-mers-e1581490460128.webp 470 987 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-26 15:23:392022-05-17 05:46:03Updated: Clinical characteristics of patients with COVID-19
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-開始-結束

開始? 結束?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-開始-結束.webp 750 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 23:07:372022-05-17 05:46:04開始? 結束?
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-

COVID-19 in Hong Kong: the end of the beginning?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-in-Hong-Kong-the-end-of-the-beginning-.jpg 760 1000 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-22 13:48:352022-05-17 05:46:03COVID-19 in Hong Kong: the end of the beginning?
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19

How do people get COVID-19 in Hong Kong

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19.webp 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:582022-05-17 05:46:03How do people get COVID-19 in Hong Kong
Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19

在本港,人們如何感染Covid-19?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-COVID-19-How-do-People-get-Covid-19-in-Hong-Kong-在本港,人們如何感染Covid-19.webp 920 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-20 21:45:452022-05-17 05:46:03在本港,人們如何感染Covid-19?
Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況

2019-nCoV – Summary of the situation in HK as of Feb 6, 2020

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:582022-02-24 07:57:172019-nCoV – Summary of the situation in HK as of Feb 6, 2020
Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況

2019-nCoV在本港的概況(截至2020年2月6日)

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-2019-nCoV-Summary-of-the-situation-in-HK-2019-nCoV在本港的概況.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-07 00:31:112022-02-24 08:01:172019-nCoV在本港的概況(截至2020年2月6日)
Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高

新型冠狀病毒(2019-nCoV)的傳染性有多高?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-04 00:49:132022-02-24 08:03:13新型冠狀病毒(2019-nCoV)的傳染性有多高?
Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高

How infectious is novel coronavirus (2019-nCoV)

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-How-infectious-is-novel-coronavirus-2019-nCoV-新型冠狀病毒-2019-nCoV-的傳染性有多高.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-03 22:33:562022-02-24 08:04:46How infectious is novel coronavirus (2019-nCoV)
Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性

2019-nCoV: how stable are coronaviruses in the environment?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:45:432022-02-24 08:07:252019-nCoV: how stable are coronaviruses in the environment?
Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性

2019-nCoV: 冠狀病毒在環境中的穩定性

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Siddharth-Sridhar-How-stable-are-coronaviruses-in-the-environment-2019-nCoV-冠狀病毒在環境中的穩定性.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-02 19:29:372022-02-24 08:09:022019-nCoV: 冠狀病毒在環境中的穩定性
Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection

Who gets severe novel coronavirus (2019-nCoV) infection?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:45:262022-02-24 08:10:40Who gets severe novel coronavirus (2019-nCoV) infection?
Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection

誰受到 2019-nCoV嚴重感染?

https://medi-paper.com/wp-content/uploads/2020/02/Dr-Sridhar-Siddharth-Who-gets-severe-novel-coronavirus-2019-nCoV-infection.jpg 1000 1500 Stijn van den Borne, MSc https://medi-paper.com/wp-content/uploads/2020/02/MediPR-MediPaper-Medical-Communications-Ltd-Healthcare-Writers-Medical-Writers-Medical-Writer-Agency-Hong-Kong-Medical-Writing-Services-Solutions-Quote-醫學寫作-香港-醫學作家香港-medical-PR-public-relations-1030x374.png Stijn van den Borne, MSc2020-02-01 23:27:182022-02-24 08:15:19誰受到 2019-nCoV嚴重感染?
Previous Previous Previous Next Next Next

© Copyright 2021 MediPaper Medical Communications Ltd. – 有關疫苗的虛假信息

Categories

Categories

Newsletter


 [‘mediPr] | MediPaper Healthcare Writers | Digital Medical Marketing | Medical Writing Solutions 醫學寫作 | Medical Writing Quote | Medical Writing Portfolio | Medical Writer Hong Kong 醫學作家香港 | Hire Healthcare Writers Hong Kong | Contact our Medical Writer Agency | MediPaper Health News | CORTiX AI for Medical Science | Dub-Dub Subtitle Generation
© 2016-2026 MediPaper Medical Communications Ltd. | Website by [’mediPr] Sydney | Singapore | Hong Kong | 醫學作家香港 | Privacy Policy | Cookie Policy
  • Link to Facebook
  • Link to LinkedIn
  • Link to X
  • Link to Instagram
  • Link to Youtube
  • Link to Mail
  • Link to Rss this site
Link to: Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions Link to: Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological Conditions Patient Blood Management and Treatment of iron Deficiency Anaemia in Gynaecological...Patient-Blood-Management-and-Treatment-of-iron-Deficiency-Anaemia-in-Gynaecological-Conditions Link to: Increasing dose frequency of lanreotide autogel injections in neuroendocrine tumours Link to: Increasing dose frequency of lanreotide autogel injections in neuroendocrine tumours Increasing-dose-frequency-of-lanreotide-autogel-injections-in-neuroendocrine-tumoursIncreasing dose frequency of lanreotide autogel injections in neuroendocrine...
Scroll to top Scroll to top Scroll to top

This site uses cookies to improve your experience. By continuing to browse the site, you are agreeing to our use of cookies.

OKPrivacy Settings×

Cookies and Privacy on medi-paper.com



Cookie Policy

How MediPaper uses cookies is explained in our Cookie Policy

Privacy Policy

Read MediPaper's Privacy Policy

Google Analytics cookies

These cookies collect information that is used either in aggregate form to help us understand how our website is being used or how effective our marketing campaigns are, or to help us customize our website and application for you in order to enhance your experience.

If you do not want that we track your visist to our site you can disable tracking in your browser here:

Other external services

We also use different external services like Google Webfonts, Google Maps and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.

Google Webfont Settings:

Google Map Settings:

Vimeo and Youtube video embeds:

5
Accept settingsHide notification only